Logo Image

Next-Generation Imaging

Latest News

January 25th 2021
Real-World data show utility of 18F-fluciclovine PET/CT in biochemically recurrent prostate cancer

Twelve percent of patients with negative results on conventional imaging had lesion localization on 18F-fluciclovine PET.

December 9th 2020

Dr. Declan G. Murphy on results of the proPSMA study of Ga 68 PSMA-11 in prostate cancer

December 1st 2020

FDA approves Gallium 68 PSMA-11 for prostate cancer

October 27th 2020

Radiotracer fluciclovine (18F) PET leads to improved cancer control in recurrent prostate cancer

Kateryna_Kon - stock.adobe.com
October 22nd 2020

18F-fluciclovine PET/CT accurately detects metastases in high-risk prostate cancer

CME Content

View More
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

View more
Integrating PSMA-Directed Radioligand Therapy in Prostate Cancer Care: Recent Data and Evolving Strategies
Video

Integrating PSMA-Directed Radioligand Therapy in Prostate Cancer Care: Recent Data and Evolving Strategies

Mary-Ellen Taplin, MD; Jeremie Calais, MD, PhD; Himanshu Nagar, MD, MS

View more